Noninvasive depression device player Neuronetics Inc. has priced an IPO that hits the trinity of positive deal indicators: strong first-day upside, pricing above the anticipated range and increasing the number of shares offered. The Malvern, Pa.-based company saw its shares climb 63 percent on the first day of trading after offering 5.5 million shares, up from the expected 5 million. It priced the offering at $17 per share, above the anticipated range of $14 to $16. Read More
